q2 adjusted earnings per share $0.41.
q3 adjusted earnings per share $0.41.
q2 sales $464.4 million versus refinitiv ibes estimate of $458.2 million.
qtrly base business revenues increased 7% compared to 2019.
q2 sales $58.4 million versus refinitiv ibes estimate of $58 million.
q2 sales $40.9 million versus refinitiv ibes estimate of $41.8 million.
qtrly adjusted ebitda before covid-19 expenses as a percentage of net sales was 18.3%.
qtrly base business net sales increased 7.1 percent to $26.4 million.